# Karuna Therapeutics Inc. (KRTX)

Source: https://www.quantisnow.com/company/KRTX
Generated: 2026-11-14T00:13:03.613Z

- Ticker: KRTX
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2019
- Website: karunatx.com

## About

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

## Latest KRTX news and filings

- 2024-04-25 09:22 UTC [Public Offering] [PureTech Announces Annual Results for Year Ended December 31, 2023](https://www.quantisnow.com/insight/puretech-announces-annual-results-for-year-ended-december-31-2023-5430980)
- 2024-03-28 20:06 UTC [SEC Form 15-12G filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-karuna-therapeutics-inc-5375653)
- 2024-03-18 20:30 UTC [SEC Form 4] [Healy James returned $466,830,870 worth of shares to the company (1,414,639 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/healy-james-returned-466830870-worth-of-shares-to-the-company-5351580)
- 2024-03-18 20:30 UTC [SEC Form 4] [Pande Atul returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/pande-atul-returned-326700-worth-of-shares-to-the-company-5351579)
- 2024-03-18 20:30 UTC [SEC Form 4] [Brown Jason Parker returned $6,985,110 worth of shares to the company (21,167 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/brown-jason-parker-returned-6985110-worth-of-shares-to-the-5351576)
- 2024-03-18 20:31 UTC [SEC Form 4] [Wheadon David E. returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/wheadon-david-e-returned-326700-worth-of-shares-to-the-5351568)
- 2024-03-18 20:30 UTC [SEC Form 4] [Jonas Jeffrey M returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/jonas-jeffrey-m-returned-326700-worth-of-shares-to-the-5351567)
- 2024-03-18 20:30 UTC [SEC Form 4] [Olson Laurie J returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/olson-laurie-j-returned-326700-worth-of-shares-to-the-5351566)
- 2024-03-18 20:30 UTC [SEC Form 4] [Torres Denice returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/torres-denice-returned-326700-worth-of-shares-to-the-company-5351565)
- 2024-03-18 20:30 UTC [SEC Form 4] [Miller Andrew Craig returned $7,718,370 worth of shares to the company (23,389 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/miller-andrew-craig-returned-7718370-worth-of-shares-to-the-5351564)
- 2024-03-18 20:30 UTC [SEC Form 4] [Paul Steven M returned $49,817,790 worth of shares to the company (150,963 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/paul-steven-m-returned-49817790-worth-of-shares-to-the-5351561)
- 2024-03-18 20:30 UTC [SEC Form 4] [Meury William returned $9,695,070 worth of shares to the company (29,379 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/meury-william-returned-9695070-worth-of-shares-to-the-company-5351558)
- 2024-03-18 20:30 UTC [SEC Form 4] [Brannan Stephen K. returned $14,059,320 worth of shares to the company (42,604 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/brannan-stephen-k-returned-14059320-worth-of-shares-to-the-5351554)
- 2024-03-18 20:30 UTC [SEC Form 4] [Coughlin Christopher J returned $326,700 worth of shares to the company (990 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/coughlin-christopher-j-returned-326700-worth-of-shares-to-the-5351553)
- 2024-03-18 20:30 UTC [SEC Form 4] [Kane William P Jr returned $4,563,240 worth of shares to the company (13,828 units at $330.00), closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/kane-william-p-jr-returned-4563240-worth-of-shares-to-5351549)
- 2024-03-18 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-karuna-therapeutics-inc-5350328)
- 2024-03-18 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-karuna-therapeutics-inc-5350327)
- 2024-03-18 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-karuna-therapeutics-inc-5350326)
- 2024-03-18 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-karuna-therapeutics-inc-5350325)
- 2024-03-18 13:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-karuna-therapeutics-inc-5350324)
- 2024-03-18 13:10 UTC [SEC Form 25-NSE filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-karuna-therapeutics-inc-5350275)
- 2024-03-18 13:08 UTC [SEC Form POSASR filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-posasr-filed-by-karuna-therapeutics-inc-5350266)
- 2024-03-18 13:04 UTC [SEC Form 8-K] [Karuna Therapeutics Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/karuna-therapeutics-inc-filed-sec-form-8-k-completion-of-acquisition-5350259)
- 2024-03-14 20:16 UTC [SEC Form 10-K] [SEC Form 10-K/A filed by Karuna Therapeutics Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-10-ka-filed-by-karuna-therapeutics-inc-amendment-5345197)
- 2024-03-14 13:31 UTC [Market Chatter] [HC Wainwright & Co. Maintains Neutral on Karuna Therapeutics, Maintains $330 Price Target](https://www.quantisnow.com/insight/hc-wainwright-co-maintains-neutral-on-karuna-therapeutics-maintains-330-5343832)
- 2024-03-14 11:26 UTC [SEC Form 8-K] [Karuna Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/karuna-therapeutics-inc-filed-sec-form-8-k-other-events-5343196)
- 2024-03-12 20:15 UTC [SEC Form 8-K] [Karuna Therapeutics Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/karuna-therapeutics-inc-filed-sec-form-8-k-submission-of-matters-5337904)
- 2024-03-11 21:10 UTC [SEC Form 4] [Brannan Stephen K. exercised 7,500 shares at a strike of $84.88 and sold $1,591,713 worth of shares (5,000 units at $318.34), increasing direct ownership by 6% to 42,604 units (SEC Form 4)](https://www.quantisnow.com/insight/brannan-stephen-k-exercised-7500-shares-at-a-strike-of-5334929)
- 2024-03-11 11:25 UTC [Market Chatter] [HC Wainwright & Co. Reiterates Neutral on Karuna Therapeutics, Maintains $330 Price Target](https://www.quantisnow.com/insight/hc-wainwright-co-reiterates-neutral-on-karuna-therapeutics-maintains-330-5332353)
- 2024-03-04 22:34 UTC [SEC Form 4] [Paul Steven M acquired $14,932,598 worth of shares (47,378 units at $315.18), gifted 90,912 shares and received a gift of 90,912 shares (SEC Form 4)](https://www.quantisnow.com/insight/paul-steven-m-acquired-14932598-worth-of-shares-47378-units-5314066)
- 2024-03-01 11:01 UTC [SEC Form 8-K] [Karuna Therapeutics Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/karuna-therapeutics-inc-filed-sec-form-8-k-other-events-5307544)
- 2024-03-01 11:02 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-karuna-therapeutics-inc-5307507)
- 2024-02-27 17:34 UTC [Market Insight] [Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect](https://www.quantisnow.com/insight/beyond-tech-and-ai-why-the-sector-hedge-funds-prefer-5295319)
- 2024-02-26 23:15 UTC [SEC Form 4] [Paul Steven M exercised 31,518 shares at a strike of $19.03, increasing direct ownership by 297% to 42,114 units (SEC Form 4)](https://www.quantisnow.com/insight/paul-steven-m-exercised-31518-shares-at-a-strike-of-5293193)
- 2024-02-22 13:20 UTC [Market Insight] [Karuna Therapeutics: Q4 Earnings Insights](https://www.quantisnow.com/insight/karuna-therapeutics-q4-earnings-insights-5283100)
- 2024-02-22 11:39 UTC [SEC Form 10-K] [SEC Form 10-K filed by Karuna Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-karuna-therapeutics-inc-5282543)
- 2024-02-22 11:33 UTC [Market Chatter] [Karuna Therapeutics Q4 EPS $(3.01) Misses $(2.65) Estimate](https://www.quantisnow.com/insight/karuna-therapeutics-q4-eps-301-misses-265-estimate-5282516)
- 2024-02-22 11:32 UTC [SEC Form 8-K] [Karuna Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/karuna-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5282515)
- 2024-02-22 11:30 UTC [Public Offering] [Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update](https://www.quantisnow.com/insight/karuna-therapeutics-reports-fourth-quarter-and-full-year-2023-financial-5282483)
- 2024-02-20 17:38 UTC [Market Chatter] [Cantor Fitzgerald Reiterates Neutral on Karuna Therapeutics, Maintains $330 Price Target](https://www.quantisnow.com/insight/cantor-fitzgerald-reiterates-neutral-on-karuna-therapeutics-maintains-330-price-5274497)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/KRTX
- Earnings history: https://www.quantisnow.com/earnings/KRTX
- Dividend history: https://www.quantisnow.com/dividends/KRTX
- Insider transactions: https://www.quantisnow.com/insiders/KRTX
- Options chain: https://www.quantisnow.com/options/KRTX
- SEC 8-K filings only: https://www.quantisnow.com/company/KRTX/8-k
- RSS and alerts for KRTX: https://www.quantisnow.com/docs/rss-feeds.md